Revolutionizing the Management of Multiple Sclerosis in Older Adults

Global experts, including leading researchers from Monash University, have collaboratively developed new guidelines aimed at improving the care of individuals over 50 living with multiple sclerosis (MS). As advancements in medical treatments increase the lifespan of MS patients, a significant demographic shift has occurred, with more than half of the global MS population now aged 50 and above. Despite this, current clinical trials, diagnostic tools, and treatment guidelines have not adapted to this aging population, often leading to challenges in accurate diagnosis, effective treatment, and quality of life improvements.

The consensus statement, published in Nature Reviews Neurology, emphasizes the urgent need for a paradigm shift in MS management for older adults. First author Associate Professor Anneke van der Walt from Monash University highlights that traditional approaches, designed for younger patients, overlook age-related changes and comorbidities, creating blind spots in care. The statement advocates for better diagnostic frameworks to distinguish MS from common age-related conditions, innovative tools to monitor disease progression considering biological aging, and tailored treatment strategies that include safe de-escalation or discontinuation of therapy when appropriate.

Additionally, the guidelines call for greater inclusion of older adults in clinical research to build evidence-based practices suited for this group. They also promote holistic, multidisciplinary care models incorporating physical activity, mental health support, and cardiovascular risk management.

Co-author Professor Helmut Butzkueven emphasizes that aging fundamentally alters MS pathology, necessitating updated science and care models that reflect this reality. The guideline sets out a roadmap to address critical gaps and urges funding agencies and policymakers to prioritize research involving older MS patients, especially those with comorbidities often excluded from trials.

Importantly, the statement underscores the importance of empowering people living with MS through enhanced access to information, personalized education, and active participation in their care decisions, ensuring that treatment evolves alongside demographic changes. This comprehensive approach aims to improve health outcomes and quality of life for the aging MS population.

Source: https://medicalxpress.com/news/2025-07-global-experts-multiple-sclerosis-older.html